EPO granted patent EP4264361A2 to Essilor International (applicants: Toh Yin Zhen Janice, Paille Damien, Garcin Gilles) covering a system and method for determining when to modify or change a myopia control solution. The patent utilizes health informatics classification codes (G16H 20/10, 20/30, 20/40, 40/63, 50/70) and relates to ophthalmic device technology (IPC: G02C 7/02, A61F 9/00, A61B 3/00). The designated states cover all EPO member states including DE, FR, GB, IT, NL, ES, and others.

This patent publication represents a formal intellectual property grant with no immediate compliance obligations for third parties. Entities developing competitive myopia control solutions should review the patent claims to assess potential licensing requirements or design-around considerations. The patent does not impose regulatory obligations but establishes enforceable intellectual property rights in designated EPO member states.